EKI Alliance, an EU firm expanding into the MENA region envisions to provide tailored consultation and turn-key business solutions.

EKI Alliance focuses on well-established asset-classes. EKI is currently developing two new ventures within these focused areas: Artificial Intelligence and Medical Device Distribution.

EKI is revolutionising the approach to Medical Device product-lifecycle management, and device distribution between the EU/UK and MENA region, by proposal of a first-of-its-kind AI platform, EK:AI.

AI: EK:AI shall vastly reduce the average 5-7 year time-to-market, solving common lifecycle- management hurdles most MedTech companies face: representing significant cost reduction, exposure to real-time consultant beating advise to combat ever changing global regulatory frameworks with increased probability of acceptance by Health Authorities on initial application. This novel platform shall augment the approach of manufacturers, governmental/healthcare bodies, physicians, and patients within the industry.

We also work on encouraging expansion, reshaping existing business blueprints; creating regulatory pathways for clients to extend their product-line opening doors to new markets. Often a difficulty with language barriers, new global regulations, contact points and authorised representatives, aligning with evolving regulations, standards, and market dynamics.

EK:AI will be able to offer Manufactures with a complete walk through the entire product-lifecycle process with on call guidance ensuring regulatory compliance from RA Intelligence, templates, documentation creation, training, audit preparation to Health authority/Notified Body questions advisory.

We take pride in our previous client relationships and representation that includes an extensive profile of world-renowned Multi-Million Dollar, Blue-Chip companies and industry expertise.

EKI Alliance, leveraging existing technology is working with specialist engineers to develop an artificially intelligent software platform.

EK:AI is open to investors looking to capitalise on the emerging AI growth within the MedTech industry and Intelligent Device Distribution.

EK: AI’s purpose is to simplify healthcare globally guiding MedTech Visionaries.

Device Distribution EKI Alliance, working closely with EU/UK manufacturers aims to open gateways, providing cutting-edge healthcare to the MENA region; still heavily reliant on device importation. Across 15-years the acerated growth within the GCC healthcare network has sky-rocketed with a market cap rising at a CGAR Rate of 5.5% year; EKI Alliance strides to provide healthcare provisions furnishing continued growth.

We project to draw the world closer together within the healthcare arena, by offering multi-international MedTech distribution services with current focus streamlined on eagerly inviting EU/UK companies to join arms with the growing healthcare industry within the GCC.

The Middle Eastern Market is projected to be worth $33.1 Billion by 2025; almost doubling in size in Approx. 10 years. With this projection in mind hospitals across the GCC will require an influx of medical device distribution. EKI Alliance is confident in offering strength and support a smooth end-to-end process.

We aim to accomplish our vision, forming a bridgeway backed by our Pannel of Project Management, Storage and Shipping handlers, Documentation controllers, Regulatory & Quality Control, and customer support team. Offering sustainability at affordable rates, we understand reducing costs broadens the scope to a wider market; directly highlighting the focus towards the delivery of care; in essence what truly matters.

Currently our distribution Investment-Window is Open.